OCT 03, 2019 1:48 PM PDT

A More Precise Version of CRISPR/Cas9 is Created

WRITTEN BY: Carmen Leitch

Several years ago, a team of researchers began a revolution in gene editing with the CRISPR/Cas9 tool, which was inspired by a defensive strategy that bacteria use against viruses that infect them. The tool can target specific parts of the genome, where it introduces cuts. One drawback of the method is that it sometimes makes those cuts in unintended places. Since CRISPR/Cas9 was created, other scientists have been perfecting and expanding the uses of the gene editor in many ways, one of which is to make the technique more precise.

Image credit: Jenna Luecke and David Steadman/Univ. of Texas at Austin

Now investigators have developed a more accurate variation of CRISPR, which reduces the number of off-target effects and may be better suited for use in gene therapy. The work has been reported in the Proceedings of the National Academy of Sciences (PNAS).

The Cas9 enzyme is the part of the CRISPR system that cuts DNA, and it’s derived from a microbe called Streptococcus pyogenes (SpCas9). In order to use the tool to repair genetic errors in humans, the CRISPR/Cas9 reagents must be delivered into human cells. A viral vector has been used to achieve that goal, called an adeno-associated virus (AAV). However, the SpCas9 is large, and the viral vector has trouble handling the molecule. A smaller version of Cas9 from a different microbe, Staphylococcus aureus (SaCas9), is much easier to fit into the delivery system. However, this enzyme is not as precise as it should be for use in patients.

In this work, the researchers aimed to make SaCas9 more specific as it seeks its target in the genome. The variant they engineered, SaCas9-HF, was shown to be more accurate as it targeted any of 24 different places in the human genome. In gene sequences with a high likelihood of off-target impacts, the SaCas9-HF reduced them by 90 percent compared to the normal SaCas9. In sequences with a low likelihood of off-target effects, the SaCas9-HF made almost no unintended cuts.

The SaCas9-HF was also good at making the right cuts. The on-target efficiency of the enzyme was 80 percent compared to the version that’s normally used; repairing genetic mutations sometimes only needs an on-target efficiency of ten percent.

"Our finding provides an alternative to the wild-type Cas9 toolbox—a new SaCas9 where highly precise genome editing is needed," said Zongli Zheng, assistant professor at the Ming Wai Lau Centre for Reparative Medicine at Karolinska Institutet in Hong Kong. "The new enzyme will be particularly useful for future gene therapy using adeno-associated viral (AAV) to deliver genome editing components in vivo."

The work must be confirmed in other types of cells to show that the unintended impacts are consistently reduced.

Learn more about CRISPR from one of the creators of the technique, Professor Jennifer Doudna.


Sources: Phys.org via Karolinska Institute, PNAS

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUL 27, 2020
Genetics & Genomics
Pediatric Cancer Mutations Show the Importance of Non-Coding Regions
JUL 27, 2020
Pediatric Cancer Mutations Show the Importance of Non-Coding Regions
A new computational tool was created by scientists at CHOP and it has now revealed new mutations that are linked to five ...
AUG 02, 2020
Genetics & Genomics
In a First, Researchers Edit Cephalopod Genes
AUG 02, 2020
In a First, Researchers Edit Cephalopod Genes
Using the CRISPR-Cas9 gene-editing tool, researchers have knocked out a gene in a cephalopod for the first time.
AUG 10, 2020
Genetics & Genomics
A Mysterious Ancestor of Humans May Lurk in Some Modern Genomes
AUG 10, 2020
A Mysterious Ancestor of Humans May Lurk in Some Modern Genomes
Modern humans are exclusively Homo sapiens, but at one point, other related species were also present in the world. Nean ...
SEP 14, 2020
Cancer
MiR-107 and Its Role in Radiosensitivity in Prostate Cancer
SEP 14, 2020
MiR-107 and Its Role in Radiosensitivity in Prostate Cancer
It is often unknown whether a patient will respond to a treatment until it is in full swing. New research is attempting ...
SEP 20, 2020
Genetics & Genomics
Errors in the Nuclear Envelope Linked to Microcephaly
SEP 20, 2020
Errors in the Nuclear Envelope Linked to Microcephaly
Researchers have found that errors in a gene called LMNB1, which produces the lamin B1 protein, have devastating effects ...
OCT 26, 2020
Genetics & Genomics
Does a 'Mismatch' Between Diet and Biology Cause Poor Health?
OCT 26, 2020
Does a 'Mismatch' Between Diet and Biology Cause Poor Health?
People that eat a 'paleo' diet operate under the idea that we should be eating more like our ancestors, and that metabol ...
Loading Comments...